Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet Breastfeeding

Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet is safe in breast-feeding or not.

What is Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet ?


fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections

Brief: Urinary analgesic

Is using Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet safe or dangerous while breastfeeding?

Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet low risk for breastfeeding
Phenazopyridine hydrochloride is the one and only active ingredient present in Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet. Phenazopyridine hydrochloride in itself is a low risk drug for lactation so it is easy to understand that Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet also comes in category of Low Risk item while breastfeeding. Below is the summary of Phenazopyridine hydrochloride in breastfeeding.

Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet Breastfeeding Analsys


Phenazopyridine hydrochloride while Breastfeeding

Low Risk

CAS Number: 94-78-0

Colorante azoico con efecto analgésico en la mucosa del tracto urinario. Uno de sus metabolitos es el paracetamol. Puede teñir las secreciones corporales de color anaranjado. Riesgo de metahemoglobinemia. A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna. Producto de farmacocinética poco estudiada y de eficacia limitada. Hasta conocer más datos sobre este fármaco, son preferibles alternativas conocidas más seguras, en especial en el periodo neonatal y en caso de prematuridad o déficit de glucosa-6PD.


Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet Breastfeeding Analsys - 2


Phenazopyridine hydrochloride while Breastfeeding

CAS Number: 94-78-0

The safety of phenazopyridine is not established in infants or during breastfeeding. Because it can cause methemoglobinemia, sulfhemoglobinemia, and hemolytic anemia, it should be avoided while breastfeeding, especially with an infant under 1 month of age or with glucose-6-phosphate dehydrogenase (G6PD) deficiency.



I am nursing mother and I have already used Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet, what should I do?

Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet so you should inform him based on your convenience.


My doctor has prescribed me Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet, what should I do?

Though Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet, will my baby need extra monitoring?

Not much monitoring required while using Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet


Who can I talk to if I have questions about usage of Uristatuti Relief Pak Uti Relief Pak | Phenazopyridine Hydrochloride Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients